Overview
- Jefferies lifted its Nvidia price target to $275 from $250 on Jan. 16 and kept a Buy rating, while J.P. Morgan reiterated Buy on Jan. 13.
- Nvidia and Eli Lilly unveiled a San Francisco Bay Area AI co-innovation lab for drug discovery with up to $1 billion in joint funding over five years.
- Jensen Huang and Dave Ricks announced the initiative at the J.P. Morgan Healthcare Conference, framing it as a blueprint for modeling complex biology.
- Wolfe Research said the newly announced 25% tariff on certain advanced semiconductors functions as a mechanism for pre-agreed payments, with limited impact on H200 China shipments.
- Recent commentary highlights ongoing investor conviction, including billionaire hedge-fund buying in Q3, alongside warnings about elevated valuations and potential AI bubble risks in 2026.